News

AddToAny

Google+ Facebook Twitter Twitter

Tissue sharing: Scheme gets traction

More than 200 scientists have signed up to a tissue-sharing database designed to reduce the number of animals needed for biomedical research.

Mouse: iStock

SEARCHBreast, led by the University of Leeds, allows breast cancer researchers across the world to search for remaining mouse tissue from previous experiments.

Project leader, Professor Valerie Speirs, said: “As scientists, we are always looking for ways to reduce the number of live animals we use in research. 
SEARCHBreast brings together those who need animal tissue and those who are holding it in their archives.

“Most scientists are willing to share this material and it makes ethical, economic, and academic sense to do that.” It is run in collaboration with the Barts Cancer Institute, the University of Sheffield, Cancer Research UK and the Beatson Institute at the University of Glasgow.

Related Articles

melanoma cell - CREDIT - science-photolibrary-f0403499

Phenotypic plasticity in melanoma: the impact on management strategies

Dr Ghada Elayat looks at the role of epithelial–mesenchymal transition in cancer and the implications for melanoma development.

A.I., Chat with AI, Artificial Intelligence-CREDIT-iStock-1494073860

AI search engines put to the test

Four proposed state-of-the-art image search engines for automating search and retrieval of digital histopathology slides were found to be of inadequate performance for routine clinical care, US research suggests.

alexandra grainey and team CREDIT_Supplied

My lab: innovative cellular pathology

A guided tour of cellular pathology at One Dorset Pathology.

big question headline

What safeguards and regulations would you like to see in place for AI pathology?

With artificial intelligence (AI) becoming ever more sophisticated and prevalent across society, combined with advances in digital pathology and the fast-paced progress in deep learning, we may be on the cusp of the era of AI in pathology. However, with technical, logistical and ethical barriers in place, we look at what measures are needed before widespread clinical adoption.

Top